| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/11/2007 | US20070010581 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010570 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010490 T-type calcium channel blockers |
| 01/11/2007 | US20070010479 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070009952 detecting susceptibility for basement membrane disease such as congenital nephrotic syndromes of the Finnish type (NPHS1); proteinuria; detecting the presence or absence of a mutation in the coding region of the gene for NPHS1 |
| 01/11/2007 | US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 01/11/2007 | US20070009514 Prostaglandin receptor ep1 |
| 01/11/2007 | US20070009444 Method for preparing powder exhibiting low susceptibility to electrification |
| 01/11/2007 | DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | CA2613627A1 Kinin antagonists for treating bladder dysfunction |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741444A1 Kinin antagonists for treating bladder dysfunction |
| 01/10/2007 | EP1740557A1 Urea derivatives as antagonists of the vanilloid receptor (vr1) |
| 01/10/2007 | EP1740532A2 Hydrazide-containing cftr inhibitor compounds and uses thereof |
| 01/10/2007 | EP1740221A2 Methods and compositions for the treatment of polycystic diseases |
| 01/10/2007 | EP1740174A1 Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatment of enuresis |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1891275A Osmotic pump type controlled release preparation of liuweidihuang or its adjusted formula extract and its preparing method |
| 01/10/2007 | CN1891258A Micropill preparation for treating chronic nephritis, and its preparing method |
| 01/10/2007 | CN1891235A Pheretima injection preparation and its preparing method |
| 01/10/2007 | CN1891217A Use of applepolyphenol for preparing medicine fortreating prostatitis or prostatic hyperplasia |
| 01/10/2007 | CN1891209A Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 01/10/2007 | CN1294134C Cyclohexylphenyl vasopression agonists |
| 01/10/2007 | CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 01/10/2007 | CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293888C Freeze dried powder injection of dandehon herb and its preparation process |
| 01/10/2007 | CN1293866C Cell growth regulating factor II and its preparation process |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160684 Methods of selecting compounds for modulation of bladder function |
| 01/09/2007 | US7160545 Useful for treatment and prevention of prostate cancer; is recognized by cytotoxic T lymphocytes |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | CA2407538C Novel bicyclic compounds |
| 01/09/2007 | CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia |
| 01/04/2007 | WO2007000985A1 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070003928 Novel use of edg receptors |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003637 Bicarbonate-based solutions for dialysis therapies |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738762A1 Preventive/remedy for diabetic complications using oligopeptide |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1737477A2 Methods of use of probiotic lactobacilli for companion animals |
| 01/03/2007 | EP1737468A2 Treatment of interstitial cystitis with vitamin d compounds |
| 01/03/2007 | EP1448168B1 Pharmaceutical formulation comprising bicalutamide |
| 01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | CN1889969A Methods for treating prostate cancer with herbal compositions |
| 01/03/2007 | CN1889968A Methods for treating prostatic intraepithelial neoplasia with herbal compositions |
| 01/03/2007 | CN1887328A Chinese medicine composition and its prepn process and quality control method |
| 01/03/2007 | CN1887314A Chinese medicine composition and its prepn process and quality control method |
| 01/03/2007 | CN1887278A Slow released doxazosin mesilate capsule and its prepn process |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |
| 01/03/2007 | CN1293049C N-hydroxyformamidine derivative |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/03/2007 | CN1292775C Medication for curing nephritis and producing method |
| 01/02/2007 | US7157604 Selective estrogen receptor modulators |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | CA2436275C Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/02/2007 | CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006137469A1 Metabotropic glutamate receptor activator |
| 12/28/2006 | WO2006104870A3 Methods of treating benign prostatic hyperplasia or lower urinary track symptoms by using pde 5 inhibitors |
| 12/28/2006 | US20060293507 Crystallization of IGF-1 |
| 12/28/2006 | US20060293351 Promotion of wound healing |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |